Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital
14
2
2
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
14%
2 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
SOFA-2 Score in Turkish ICUs
Role: lead
Closed Loop Ventilation With High Tidal Volumes and Safe Transpulmonary Pressure in COPD (COPD-SAFE)
Role: lead
Telerehabilitation in COPD
Role: lead
Screening of Sleep Apnea by Holter Electrocardiography: Validation of Heart Rate Variability Analysis Algorithm
Role: lead
Open Suction vs. Closed Suction in ARDS
Role: lead
Closed Loop Ventilation in Patients With COVID-19
Role: lead
Long Term Outcomes of Coronavirus Disease-19 (COVID-19)
Role: lead
Turkish Version of the Individual Knowledge Statement Questionnaire of Chronic Obstructive Pulmonary Disease (COPD)
Role: collaborator
Intellivent ASV in Chronic Obstructive Pulmonary Disease Patients in the ICU
Role: lead
Patient Factors Associated With Prescription of Antibiotics for Inappropriate Indication in Patients With AECOPD
Role: lead
Paraoxanase Enzyme Activity in Patients With Pulmonary Diseases
Role: lead
Closed Loop Ventilation Strategy in Intensive Care Unit (ICU) Patients
Role: lead
The Effect of Pure Prone Positioning Therapy for the Patients With Mild to Moderate Obstructive Sleep Apnea
Role: lead
Adaptive Support Ventilation in the Weaning of COPD
Role: lead
All 14 trials loaded